DERMATA THERAPEUTICS, INC.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2021 | $-776.2K | $-776.2K | — | $1.2M |
| Jun 2021 | $-903.2K | $-903.2K | — | $114.0K |
| Sep 2021 | $-2.2M | $-2.2M | — | $142.7K |
| Dec 2021 | $-1.8M | $-1.8M | — | $488.7K |
| Mar 2022 | $-2.6M | $-2.6M | — | $212.9K |
| Jun 2022 | $-1.8M | $-1.8M | — | $261.6K |
| Sep 2022 | $-2.6M | $-2.6M | — | $235.0K |
| Dec 2022 | $-1.8M | $-1.8M | — | $220.9K |
| Mar 2023 | $-1.6M | $-1.6M | — | $131.3K |
| Jun 2023 | $-1.8M | $-1.8M | — | $131.2K |
| Sep 2023 | $-1.8M | $-1.8M | — | $131.2K |
| Dec 2023 | $-1.1M | $-1.1M | — | $128.5K |
| Mar 2024 | $-2.7M | $-2.7M | — | $587.2K |
| Jun 2024 | $-2.1M | $-2.1M | — | $19.6K |
| Sep 2024 | $-3.4M | $-3.4M | — | $21.0K |
| Dec 2024 | $-2.9M | $-2.9M | — | $29.8K |
| Mar 2025 | $-1.9M | $-1.9M | — | $37.2K |
| Jun 2025 | $-2.7M | $-2.7M | — | $39.2K |
| Sep 2025 | $-1.8M | $-1.8M | — | $37.8K |
| Dec 2025 | $-1.3M | $-1.3M | — | $29.5K |
| Mar 2026 | $-2.5M | $-2.5M | — | $43.3K |
| Jun 2026 | $-2.4M | $-2.4M | — | $41.8K |